Treatment preferences in low-risk papillary thyroid microcarcinoma: a discrete choice experiment. [PDF]
Wang S +7 more
europepmc +1 more source
Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute +17 more
wiley +1 more source
Preference for breast cancer screening in Chinese women: Discrete choice experiment. [PDF]
Wu S +10 more
europepmc +1 more source
Patients’ preferences and economic considerations play an important role in treatment decisions: a discrete choice experiment among rheumatologists [PDF]
Monika Hifinger +6 more
openalex +1 more source
Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller +17 more
wiley +1 more source
Colorectal Cancer Screening Preferences of Recipients and Providers: A Dual-Perspective Discrete Choice Experiment. [PDF]
Guan W +10 more
europepmc +1 more source
Patient preferences for adverse effects of intraocular pressure‐lowering eye drops. Results from a Danish large‐scale discrete choice experiment: These adverse effects matter to the patients [PDF]
Alexander von Spreckelsen +8 more
openalex +1 more source

